Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by edmedon Apr 11, 2015 11:49am
124 Views
Post# 23619529

RE:RE:RE:Known Information overview

RE:RE:RE:Known Information overview
It is all about price and quality control.
In order to execute their plan Management is going to have to get their product into pharmacies.  Outsourcing generic medication from overseas should allow them to offer pharmacies a better financial arrangement than generic companies that manufacture in North America.

There is no question that with the aging population and medical costs spiraling out of control, Provincial governments are alway looking for ways to save money.

Ontario with its huge financial deficits are ripe for a better deal for its generic drug plan otherwise known as the ODB

Managment must ensure quality control on these shipments....the generic medication must be up to Canadian standards for VANC to succeed

If the price is right and the meds are of good quality........the float is still reasonable and it pays to be long here....

those are my thoughts
edmed
Bullboard Posts